Free Trial
→ Elon Musk’s $1 Quadrillion AI IPO (From Brownstone Research) (Ad)tc pixel Free INKT Stock Alerts
Live Earnings Conference Call: MiNK Therapeutics will host a live Q1 2026 earnings call on May 15, 2026 at 8:30AM ET. Follow this link to get details and listen to MiNK Therapeutics' Q1 2026 earnings call when it goes live. Get details.

MiNK Therapeutics (INKT) Institutional Ownership

MiNK Therapeutics logo
$10.51 -0.54 (-4.89%)
Closing price 05/14/2026 04:00 PM Eastern
Extended Trading
$11.16 +0.65 (+6.14%)
As of 05/14/2026 07:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Institutional Ownership Changes (13F Filings) for MiNK Therapeutics (NASDAQ:INKT)

Current
Institutional Ownership
Percentage
2.87%
Number of
Institutional Buyers
(last 12 months)
2
Total
Institutional Inflows
(last 12 months)
$302.37K
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$46.83K
Get INKT Insider Trade Alerts

Want to know when executives and insiders are buying or selling MiNK Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

INKT Institutional Buying and Selling by Quarter

MiNK Therapeutics Major Shareholders & Ownership History

Export
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/12/2026 DRW Securities LLC25,677$286K0.0%N/A0.547%
2/12/2026Renaissance Technologies LLC10,400$116K0.0%-28.8%0.222%
2/9/2026Geode Capital Management LLC14,247$159K0.0%+11.3%0.304%
5/7/2025Longbow Finance SA16,667$144K0.0%-90.0%0.420%
2/13/2025Renaissance Technologies LLC101,707$71K0.0%-4.7%2.566%
2/12/2025Geode Capital Management LLC96,113$67K0.0%-1.9%2.427%
2/7/2025HighTower Advisors LLC50,676$35K0.0%-2.0%1.280%
8/9/2024Renaissance Technologies LLC127,841$121K0.0%+21.5%0.368%
11/14/2023Oracle Investment Management Inc.36,898$41K0.0%-26.9%0.107%
8/14/2023Oracle Investment Management Inc.50,461$106K0.1%N/A0.146%
8/14/2023Deep Track Capital LP324,867$682K0.0%N/A0.941%
8/11/2023Artal Group S.A.228,216$479K0.0%-21.2%0.663%
7/27/2023Virtu Financial LLC14,232$30K0.0%N/A0.041%
2/10/2023StoneX Group Inc.17,821$47K0.0%N/A0.053%
11/4/2022First Republic Investment Management Inc.81,500$172K0.0%N/A0.243%
2/15/2022Sofinnova Investments Inc.345,499$1.54M0.1%N/A1.031%


INKT Institutional Ownership - Frequently Asked Questions

During the previous two years, the following institutional investors and hedge funds held shares of MiNK Therapeutics shares: DRW Securities LLC ($286K), Geode Capital Management LLC ($159K), Longbow Finance SA ($144K), and Renaissance Technologies LLC ($116K), HighTower Advisors LLC ($35K).Learn more on MiNK Therapeutics' institutional investors.

2.87% of MiNK Therapeutics' stock is owned by institutional investors. Learn more on INKT's institutional investor holdings.

The following institutional investors have purchased MiNK Therapeutics' stock in the last 24 months: DRW Securities LLC ($25.68K), Renaissance Technologies LLC ($22.61K), and Geode Capital Management LLC ($1.44K).

Institutional investors have bought a total of 27,118 shares in the last 24 months. This purchase volume represents approximately $302.37K in transactions.

The following institutional investors have sold MiNK Therapeutics stock in the last 24 months: Renaissance Technologies LLC ($4.20K).

Institutional investors have sold a total of 4,200 shares in the last 24 months. This volume of shares sold represents approximately $46.83K in transactions.


Related Companies

This page (NASDAQ:INKT) was last updated on 5/15/2026 by MarketBeat.com Staff.
From Our Partners
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...
Paradigm Press | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Why this tiny stock may move before the SpaceX IPO drops
The projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...
Behind the Markets | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel